CMRA - Director at Comera Life Sciences Acquires Company Stock Options Worth 75376 Shares | Benzinga
William Wexler, Director at Comera Life Sciences (NASDAQ:CMRA), reported a large acquisition of company stock options on November 14, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Wexler, Director at Comera Life Sciences, a company in the Health Care sector, was just awarded stock options worth 75,376 shares of CMRA. The options give Wexler the right to buy the company's stock at $0.32 per share.
Comera Life Sciences shares are trading up 4.38% at $0.25 at the time of this writing on Wednesday morning. Since the current price is $0.25, this makes Wexler's 75,376 shares worth $18,489.